Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections.

about

Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections.

Item

http://www.wikidata.org/entity/Q40845477

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Clinical pharmacological appro ...... nt of MRSA-related infections.

@en

type

Item

label

Clinical pharmacological appro ...... nt of MRSA-related infections.

@en

prefLabel

Clinical pharmacological appro ...... nt of MRSA-related infections.

@en

P1476

Clinical pharmacological appro ...... nt of MRSA-related infections.

@en

P2093

Javier Garau

http://www.w3.org/2001/XMLSchema#string

Nicola Petrosillo

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents

Immunological monitoring to prevent and treat sepsis

Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model

Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia

Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.

Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.

Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")

P304

927-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2015.1056159

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Federico Pea

Javier Garau

Nicola Petrosillo

P577

2015-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26065544

http://www.w3.org/2001/XMLSchema#string